Detail akcie Ingen Tech online

Business Summary: Ingen Technologies, Inc. is engaged in research and development of home healthcare products for the respiratory market. The Company develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs. It is a cause of death, illness and disability in the United States, and other countries. The Company’s products include The Smart Nasal Cannula 206NCA (Adult Size), The Smart Nasal Cannula 203NCA (Adult Size), The Smart Nasal Cannula 206NCP (Child Size), The Smart Nasal Cannula 203NCP (Child Size), The Smart Nasal Cannula 206NC (Infant Size), The Smart Nasal Cannula 203NC (Infant Size), Oxyview 203A And Oxyview 206A.
Financial Summary: BRIEF: For the three months ended 31 August 2013, Ingen Technologies Inc revenues increased from $0K to $2K. Net income totaled $2.4M vs. loss of $604K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Change in derivative liability increase from $0K to $2.4M (income), Interest expenses decrease from $569K (expense) to $0K, Selling.